Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.99 - $2.91 $192,456 - $565,706
194,401 New
194,401 $229,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $2.27 $20,273 - $354,011
155,952 Added 1310.63%
167,851 $342,000
Q2 2022

Aug 15, 2022

BUY
$1.54 - $6.48 $740 - $3,116
481 Added 4.21%
11,899 $18,000
Q1 2022

May 11, 2022

BUY
$3.67 - $7.63 $41,904 - $87,119
11,418 New
11,418 $58,000

Others Institutions Holding PEAR

About Pear Therapeutics, Inc.


  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.